New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Calorie restriction may rejuvenate muscles and activate biological pathways for healthy aging

Calorie restriction may rejuvenate muscles and activate biological pathways for healthy aging

Reducing overall calorie intake may rejuvenate your muscles and activate biological pathways important for good health, according to researchers at the National Institutes of Health and their colleagu
World medicine November 09,2023
Calorie restriction may rejuvenate muscles and activate biological pathways for healthy aging

Calorie restriction may rejuvenate muscles and activate biological pathways for healthy aging

Reducing overall calorie intake may rejuvenate your muscles and activate biological pathways important for good health, according to researchers at the National Institutes of Health and their colleagu
World medicine November 09,2023
Research suggests potential connection between gut bacteria and onset of colorectal lesions and cancers

Research suggests potential connection between gut bacteria and onset of colorectal lesions and cancers

New research has identified significant variations in the gut microbiome of individuals who developed pre-cancerous colonic lesions, suggesting a potential connection between gut bacteria and the onse
World medicine November 09,2023
Research suggests potential connection between gut bacteria and onset of colorectal lesions and cancers

Research suggests potential connection between gut bacteria and onset of colorectal lesions and cancers

New research has identified significant variations in the gut microbiome of individuals who developed pre-cancerous colonic lesions, suggesting a potential connection between gut bacteria and the onse
World medicine November 09,2023
Gedatolisib Triplet Shows Early Efficacy in Previously Untreated ER+/HER2– Breast Cancer

Gedatolisib Triplet Shows Early Efficacy in Previously Untreated ER+/HER2– Breast Cancer

The addition of gedatolisib to palbociclib (Ibrance) and letrozole produced durable responses with comparable safety to that observed with palbociclib and letrozole alone in treatment-naïve patients w
World medicine November 09,2023
Gedatolisib Triplet Shows Early Efficacy in Previously Untreated ER+/HER2– Breast Cancer

Gedatolisib Triplet Shows Early Efficacy in Previously Untreated ER+/HER2– Breast Cancer

The addition of gedatolisib to palbociclib (Ibrance) and letrozole produced durable responses with comparable safety to that observed with palbociclib and letrozole alone in treatment-naïve patients w
World medicine November 09,2023
Garsorasib Plus Cetuximab Shows Early Efficacy in Heavily Pretreated KRAS G12C+ CRC

Garsorasib Plus Cetuximab Shows Early Efficacy in Heavily Pretreated KRAS G12C+ CRC

The combination of garsorasib (D-1553) and cetuximab (Erbitux) elicited responses and was found to be well tolerated in heavily pretreated patients withKRASG12C–mutated colorectal cancer (
World medicine November 09,2023
Garsorasib Plus Cetuximab Shows Early Efficacy in Heavily Pretreated KRAS G12C+ CRC

Garsorasib Plus Cetuximab Shows Early Efficacy in Heavily Pretreated KRAS G12C+ CRC

The combination of garsorasib (D-1553) and cetuximab (Erbitux) elicited responses and was found to be well tolerated in heavily pretreated patients withKRASG12C–mutated colorectal cancer (
World medicine November 09,2023
Virtual reality can help calm caregivers of surgery-bound children

Virtual reality can help calm caregivers of surgery-bound children

Virtual reality (VR) may be an effective and reliable tool to alleviate the anxiety experienced by most parents or caregivers when their child undergoes surgery, according to research presented at the
World medicine November 09,2023
Virtual reality can help calm caregivers of surgery-bound children

Virtual reality can help calm caregivers of surgery-bound children

Virtual reality (VR) may be an effective and reliable tool to alleviate the anxiety experienced by most parents or caregivers when their child undergoes surgery, according to research presented at the
World medicine November 09,2023
AI-powered unbiased pain detection system holds promise for improving patient care

AI-powered unbiased pain detection system holds promise for improving patient care

An automated pain recognition system using artificial intelligence (AI) holds promise as an unbiased method to detect pain in patients before, during and after surgery, according to research presented
World medicine November 09,2023
AI-powered unbiased pain detection system holds promise for improving patient care

AI-powered unbiased pain detection system holds promise for improving patient care

An automated pain recognition system using artificial intelligence (AI) holds promise as an unbiased method to detect pain in patients before, during and after surgery, according to research presented
World medicine November 09,2023
Duvelisib Demonstrates Higher Activity in Angioimmunoblastic Peripheral T-Cell Lymphoma

Duvelisib Demonstrates Higher Activity in Angioimmunoblastic Peripheral T-Cell Lymphoma

Treatment with duvelisib (Copiktra) led to a high response rate in patients with peripheral T-cell lymphoma (PTCL), with activity favoring patients with PTCL not otherwise specified (NOS) and angioimm
World medicine November 09,2023
Duvelisib Demonstrates Higher Activity in Angioimmunoblastic Peripheral T-Cell Lymphoma

Duvelisib Demonstrates Higher Activity in Angioimmunoblastic Peripheral T-Cell Lymphoma

Treatment with duvelisib (Copiktra) led to a high response rate in patients with peripheral T-cell lymphoma (PTCL), with activity favoring patients with PTCL not otherwise specified (NOS) and angioimm
World medicine November 09,2023
AI innovation "Sturgeon" transforms classification of central nervous system malignancies

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

In a recent study published inNature, researchers developed Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of central nervous system (CNS) ma
World medicine November 09,2023
AI innovation "Sturgeon" transforms classification of central nervous system malignancies

AI innovation "Sturgeon" transforms classification of central nervous system malignancies

In a recent study published inNature, researchers developed Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of central nervous system (CNS) ma
World medicine November 09,2023
CMG901 Elicits Responses in CLDN18.2-Expressing Gastric/GEJ Cancer

CMG901 Elicits Responses in CLDN18.2-Expressing Gastric/GEJ Cancer

The antibody-drug conjugate (ADC) CMG901 induced responses with a manageable toxicity profile in patients with CLDN18.2-positive gastric or gastroesophageal junction (GEJ) cancer, according to updated
World medicine November 09,2023
CMG901 Elicits Responses in CLDN18.2-Expressing Gastric/GEJ Cancer

CMG901 Elicits Responses in CLDN18.2-Expressing Gastric/GEJ Cancer

The antibody-drug conjugate (ADC) CMG901 induced responses with a manageable toxicity profile in patients with CLDN18.2-positive gastric or gastroesophageal junction (GEJ) cancer, according to updated
World medicine November 09,2023
AI chatbot ChatGPT may not be accurate enough for self-diagnosis

AI chatbot ChatGPT may not be accurate enough for self-diagnosis

ChatGPT, a sophisticated chatbot driven by artificial intelligence (AI) technology, has been increasingly used in health care contexts, one of which is assisting patients in self-diagnosing before see
World medicine November 09,2023
AI chatbot ChatGPT may not be accurate enough for self-diagnosis

AI chatbot ChatGPT may not be accurate enough for self-diagnosis

ChatGPT, a sophisticated chatbot driven by artificial intelligence (AI) technology, has been increasingly used in health care contexts, one of which is assisting patients in self-diagnosing before see
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com